简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Enovix Stock Is Tumbling Thursday: What's Going On?

2025-08-01 06:16

Enovix Corp (NASDAQ:ENVX) reported financial results for the second quarter after the market close on Thursday. Shares are moving lower in after-hours trading. Here’s a look at the key highlights from the quarter.

  • Q2 Revenue: $7.47 million, versus estimates of $5.57 million
  • Q2 Adjusted EPS: Loss of 13 cents, versus estimates for a loss of 17 cents

Total revenue was up 98% on a year-over-year basis, driven by “strong demand” for the lithium-ion battery company’s products. Enovix highlighted the launch of its AI-1 cell platform, a core battery architecture featuring advanced materials and a fully automated manufacturing process.

“In the second quarter of 2025, Enovix delivered on key milestones in product development, manufacturing readiness and commercialization. We finalized the AI-1 battery platform, shipped production samples for product qualification, exceeded revenue expectations, and achieved our third straight quarter of positive gross margin,” the company said in a letter to shareholders.

“With AI-1 launched, mass production advancing, and new customers entering qualification, we are moving into the commercialization phase.”

Enovix ended the period with $203.4 million in total cash, cash equivalents and short-term investments.

Guidance: Enovix expects third-quarter revenue to be between $7.5 million and $8.5 million versus estimates of $7.3 million. The company anticipates a third-quarter loss of 14 cents to 18 cents per share versus estimates for a loss of 18 cents per share.

ENVX Price Action: Enovix shares were down 17.61% in after-hours, trading at $11.04 at the time of publication on Thursday, according to Benzinga Pro.

Read Next:

  • Amazon Q2 Earnings Highlights: Double Beat, ‘AI Progress Across The Board Continues’
  • Elon Musk’s Tesla, LG Energy Solutions Sign $4.3 Billion Battery Deal

Image: Tada Images/Shutterstock.com

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。